glp 1 and breast cancer A trio of large observational studies reported at the San Antonio Symposium (SABCS) 2025 suggest that GLP-1 receptor agonists may improve outcomes in some women with breast cancer. Two studies The effect of GLP-1R agonists

And in several recent studies, they show early promise in preventing many common cancers including breast, colon, liver, and ovarian known to be driven by obesity and excess weight

2020, doi: 10.1016/S2213-8587(19)30382-1

This defect seems specific to neuronal lineage cells, as other cell types carrying the same mutations did not exhibit the same detrimental phenotypes

We flag it only to be complete and honest about where the science actually stands, because responsible information means clearly separating what is proven from what is still being studied

If I may share the basics of the protocol, the invention was 25yrs in the making, the inventor & his team were very successfully able to wrap the fragile rate limiting cysteine molecule with riboceine, to protect it through the gut, into the cell whereby the cysteine molecule remained in the cell to do its thing & the ribose enters the mitochondria as energy